Insider Transactions in Q3 2023 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,501
-2.1%
|
$114,076
$76.99 P/Share
|
Sep 10
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,203
-1.09%
|
$91,428
$76.0 P/Share
|
Sep 10
2023
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,619
+2.32%
|
-
|
Sep 10
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,256
-1.38%
|
$95,456
$76.0 P/Share
|
Sep 10
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,730
+2.92%
|
-
|
Sep 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-0.49%
|
$11,324
$76.0 P/Share
|
Sep 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
519
+1.69%
|
-
|
Sep 10
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,278
-1.75%
|
$97,128
$76.0 P/Share
|
Sep 10
2023
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,779
+3.67%
|
-
|
Sep 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,366
-0.87%
|
$255,816
$76.0 P/Share
|
Sep 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,348
+1.86%
|
-
|
Aug 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
1,306
-4.2%
|
$104,480
$80.0 P/Share
|
Aug 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
4,484
+12.62%
|
-
|
Jul 25
2023
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,289
+36.48%
|
-
|
Jul 25
2023
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,174
-48.5%
|
$321,398
$77.23 P/Share
|
Jul 24
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,174
-6.16%
|
$244,398
$77.66 P/Share
|
Jul 24
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,505
+12.72%
|
-
|
Jul 20
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.44%
|
$400,000
$80.0 P/Share
|